Johnson AC. Hippocampal vascular supply and its role in vascular cognitive impairment. Stroke. 2023;54:673–85. https://doi.org/10.1161/STROKEAHA.122.038263.
Article CAS PubMed PubMed Central Google Scholar
Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:3326–44. https://doi.org/10.1016/j.jacc.2019.04.034.
Article PubMed PubMed Central Google Scholar
Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312:H1–20. https://doi.org/10.1152/ajpheart.00581.2016.
Gorelick PB, Counts SE, Nyenhuis D. Vascular cognitive impairment and dementia. Biochim Biophys Acta. 2016;1862:860–8. https://doi.org/10.1016/j.bbadis.2015.12.015.
Article CAS PubMed Google Scholar
Mahinrad S, Sorond F, Gorelick PB. The role of vascular risk factors in cognitive impairment and dementia and prospects for prevention. Clin Geriatr Med. 2023;39:123–34. https://doi.org/10.1016/j.cger.2022.07.007.
Wolters FJ, Ikram MA. Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol. 2019;39:1542–9. https://doi.org/10.1161/ATVBAHA.119.311908.
Article CAS PubMed Google Scholar
Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int. 2014;2014:908915. https://doi.org/10.1155/2014/908915.
Article PubMed PubMed Central Google Scholar
Rocca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM, Dartiques J-F, Engedal K, Hagnell O, Heeren TJ, et al. The prevalence of vascular dementia in Europe: facts and fragments from 1980–1990 studies. Ann Neurol. 1991;30:817–24. https://doi.org/10.1002/ana.410300611.
Article CAS PubMed Google Scholar
Hébert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14:240–57. https://doi.org/10.1159/000109800.
Tong X, Yang Q, Ritchey MD, George MG, Jackson SL, Gillespie C, Merritt RK. The burden of cerebrovascular disease in the United States. Prev Chronic Dis. 2019;16:E52. https://doi.org/10.5888/pcd16.180411.
Article PubMed PubMed Central Google Scholar
Eurostat: aging Europe. https://ec.europa.eu/eurostat/cache/digpub/ageing/. Accessed on 11 April 2022
World Health Organization. Health data overview for Japan. https://data.who.int/countries/392. Accessed on 10 Feb 2023
“Aging in the United States”. Population Reference Bureau, 2021, https://www.prb.org/aging-unitedstates-fact-sheet/. Accessed on 05 Sept 2023
United States Census Bureau. 2020 Census: 1 in 6 People in the United States Were 65 and Over. https://www.census.gov/library/stories/2023/05/2020-census-united-states-older-population-grew.html. Accessed on 10 Feb 2023
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7:e105–25. https://doi.org/10.1016/S2468-2667(21)00249-8.
Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D, Bloom DE. Global and regional projections of the economic burden of Alzheimer’s disease and related dementias from 2019 to 2050: a value of statistical life approach. EClinicalMedicine. 2022;51:101580. https://doi.org/10.1016/j.eclinm.2022.101580.
Article PubMed PubMed Central Google Scholar
Han EJ, Lee J, Cho E, Kim H. Socioeconomic costs of dementia based on utilization of health care and long-term-care services: a retrospective cohort study. Int J Environ Res Public Health. 2021;18. https://doi.org/10.3390/ijerph18020376
Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21–78. https://doi.org/10.1152/physrev.00050.2017.
Article CAS PubMed Google Scholar
Nyul-Toth A, Tarantini S, DelFavero J, Yan F, Balasubramanian P, Yabluchanskiy A, Ahire C, Kiss T, Csipo T, Lipecz A, et al. Demonstration of age-related blood-brain barrier disruption and cerebromicrovascular rarefaction in mice by longitudinal intravital two-photon microscopy and optical coherence tomography. Am J Physiol Heart Circ Physiol. 2021;320:H1370–92. https://doi.org/10.1152/ajpheart.00709.2020.
Article CAS PubMed PubMed Central Google Scholar
Fulop GA, Ahire C, Csipo T, Tarantini S, Kiss T, Balasubramanian P, Yabluchanskiy A, Farkas E, Toth A, Nyul-Toth A, et al. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice. Geroscience. 2019;41:575–89. https://doi.org/10.1007/s11357-019-00110-1.
Article CAS PubMed PubMed Central Google Scholar
Tucsek Z, Toth P, Sosnowsk D, Gautam T, Mitschelen M, Koller A, Szalai G, Sonntag WE, Ungvari Z, Csiszar A. Obesity in aging exacerbates blood brain barrier disruption, neuroinflammation and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer’s disease. J Gerontol A Biol Sci Med Sci. 2014;69:1212–26.
Article CAS PubMed Google Scholar
Van Skike CE, Jahrling JB, Olson AB, Sayre NL, Hussong SA, Ungvari Z, Lechleiter JD, Galvan V. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2018;314:H693–703. https://doi.org/10.1152/ajpheart.00570.2017.
Article CAS PubMed Google Scholar
Miller LR, Tarantini S, Nyul-Toth A, Johnston MP, Martin T, Bullen EC, Bickel MA, Sonntag WE, Yabluchanskiy A, Csiszar A, et al. Increased susceptibility to cerebral microhemorrhages is associated with imaging signs of microvascular degeneration in the retina in an insulin-like growth factor 1 deficient mouse model of accelerated aging. Front Aging Neurosci. 2022;14:788296. https://doi.org/10.3389/fnagi.2022.788296.
Article CAS PubMed PubMed Central Google Scholar
Nyul-Toth A, Fulop GA, Tarantini S, Kiss T, Ahire C, Faakye JA, Ungvari A, Toth P, Toth A, Csiszar A, Ungvari Z. Cerebral venous congestion exacerbates cerebral microhemorrhages in mice. Geroscience. 2022;44:805–16. https://doi.org/10.1007/s11357-021-00504-0.
Article PubMed PubMed Central Google Scholar
Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Springo Z, Fulop GA, Ashpole N, Gautam T, Giles CB, Wren JD, Sonntag WE, et al. Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype. Aging Cell. 2017;16:469–79. https://doi.org/10.1111/acel.12583.
Article CAS PubMed PubMed Central Google Scholar
Toth P, Tarantini S, Springo Z, Tucsek Z, Gautam T, Giles CB, Wren JD, Koller A, Sonntag WE, Csiszar A, Ungvari Z. Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell. 2015;14:400–8. https://doi.org/10.1111/acel.12315.
Article CAS PubMed PubMed Central Google Scholar
Ungvari Z, Tarantini S, Kirkpatrick AC, Csiszar A, Prodan CI. Cerebral microhemorrhages: mechanisms, consequences, and prevention. Am J Physiol Heart Circ Physiol. 2017;312:H1128–43. https://doi.org/10.1152/ajpheart.00780.2016.
Article PubMed PubMed Central Google Scholar
Riddle DR, Sonntag WE, Lichtenwalner RJ. Microvascular plasticity in aging. Ageing Res Rev. 2003;2:149–68.
Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997;138:3515–20.
Article CAS PubMed Google Scholar
Tucsek Z, Toth P, Tarantini S, Sosnowska D, Gautam T, Warrington JP, Giles CB, Wren JD, Koller A, Ballabh P, et al. Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice. J Gerontol A Biol Sci Med Sci. 2014;69:1339–52. https://doi.org/10.1093/gerona/glu080.
留言 (0)